All Episodes
The Evidence Based Rheumatology Podcast — 101 episodes
E135: IL17 and a GLP1?
E134: Brepocitinib in Dermatomyositis (VALOR)
E133: Obinutuzumab for SLE (ALLEGORY)
E132: Romosozumab vs teriparatide for osteoproosis (STRUCTURE)
E131: A Sham-Controlled Sham of a Trial: RESET-RA
E130: Telitacicept for SLE
E129: Long Term Routine Laboratory Monitoring in RA
E128: Nerandomilast for Autoimmune ILD (FIBRONEER-ILD)
E127: TNFs and All That CHF
E126: Risk Signals, JAKs, and SELECTIVE-ity
E125: Adrenal Insufficiency after Stopping Prednisone
e124: MTX vs Pred for Pulmonary Sarcoidosis: PREDMETH Study
E123: Upadacitinib for Giant Cell Arteritis: SELECT-GCA
E122: Guidelines for Maybe Diagnosing HLH
E121: Obinutuzumab in SLE-LN
E120: Real Life Use of PEXIVAS-Low
E119: Teclistamab for Rheumatology Writ Large
E118: The emerging risk of overdiagnosis in RA and PMR
E117: Inebilizumab for IgG4-RD (MITIGATE)
E116: A New Paradigm for PMR
E115: Benralizumab for EGPA - the MANDARA Study
E114: Target Trials and STAR-RA with Rishi Desai
E113: CAR-T is Coming to Rheumatology
E112: Gabapentin is Trash
E111: PEXIVAS Subsets with Mike Walsh & Mats Junek
E110: Rheum4Debate - Screening for RA-ILD with Joshua Solomon and Scott Matson
E109: Abatacept for Pre-RA - the ARIAA Study
E108: Myositis Guidelines for Cancer Screening w/Alexander Oldroyd
E107: Fragility of SLE Randomized Controlled Trials
E106: GCA/PMR with Bhaskar Dasgupta
E105: Autoimmunity Post COVID-19?
E104: Sarilumab for PMR - The SAPHYR Study
E103: Len Calabrese on Monoclonal Antibodies for COVID-19
E102: Unintentional Unblinding in Rheumatic Disease Trials
E101: Pred v Colchicine for CPPD: COLCHICORT
E100: ADVOCATE Health Related Quality of Life
E99: Hospital Problems
E98: Key Opinion Leaders & ILD Guidelines
E97: Does allopurinol reduce CVD? The ALLHEART Study
E96: Long COVID - Where to After Norway?
E95: Rituximab or Cyclophosphamide in ANCA Vasculitis
E94: Steroids and Psoriasis Flares
E93: Azathioprine is the Worst
E92: Are muscle symptoms from statins imaginary?
E91: Clinical Innovation in Rheumatology: Past, Present, and Future
E90: There Is No Diagnosis of Exclusion in Rheumatology
E89: Vitamin D to Prevent Osteoporotic Fractures
E88: HCQ Dose Reductions and SLE Flares
E87: IVIG for Dermatomyositis
E86: Target Trials and Causality in Rheumatology
E85: Challenging Wisely
E84: The JAKapocalypse (AKA ORAL Surveillance)
E83: Effectiveness of COVID-19 Vaccines
E82: LoVAS Trial for ANCA Vasculitis
E81: Vasculitis Guidelines E7: Takayasu Arteritis with Dr. Andy Abril
E80: Vasculitis Guidelines E6 - Polyarteritis Nodosa with Dr. Jason Springer
E79: Vasculitis Guidelines E5 - GCA with Dr. Mehrdad Maz
E78: Vasculitis Guidelines #4 - EGPA with Dr. Phil Seo
E77: Vasculitis Guidelines #3 - ANCA Vasculitis with Dr. Sharon Chung
E76: Voclosporin for SLE Nephritis: The AURORA RCT
E75: Vasculitis Guidelines Episode 2: Overview with Sharon Chung
E74: Vasculitis Guidelines Episode 1 - Joyce Kullman
E73: Introducing the Vasculitis Guidelines Podcast
E72: Avacopan for ANCA Vasculitis
E71: MTX Discontinuation Post... Influenza Vaccination
E70: Rheum4Debate - HCQ Levels Should Be Monitored in Patients with SLE
E69: Publication Trends in SRMAs and RCTs
E68: SELECT-CHOICE Upadacitinib vs Abatacept in RA
E67: Belimumab in Lupus Nephritis (BLISS-LN)
E66: MRI to Diagnose PMR
E65: Anifrolumab in SLE - A Reply
E63: Housekeeping #3
E57: PEXIVAS Trial - PLEX and Reduced Steroid in ANCA Vasculitis
E56: Continue or Withdraw Prednisone in SLE (CORTICOLUP)
E55: Anifrolumab for SLE (TULIP 1&2)
E54: Rheum4Debate - Triple Tx is 1st Line in RA w/No Response to MTX
E53: Another Look at Nintedanib for SSc-ILD
E52: HOPE RCT - Prednisone for OA of the Hand
E51: Rheum4Debate - "Start TCZ Upfront in GCA"
E50: Housekeeping 2
E49: IL17i vs. TNFi for Psoriatic Arthritis (SPIRIT-H2H)
E48: ADACTA - Tocilizumab or Adalimumab in MTX Intolerant Patients with RA
E47: HCQ Blood Levels and HCQ Retinopathy
E46: Rituximab in Lupus
E45: TNF or TCZ or ABA or RTX: Real World Data for RA
E44: SELECT-COMPARE Upadacitinib (JAKi) for Rheumatoid Arthritis
E43: Tofacitinib for MDA5 Amyopathic Dermatomyositis ILD
E42: SENSCIS - Nintedanib for Systemic Sclerosis ILD
E41: Rheum4Debate "SLE Pts. on Cytoxan Should Receive Bactrim"
E40: Rheum4Debate - "SCT is 1st Line Tx for SSc ILD"
E39: MTX for GCA - 3 RCTs and a Case Control Study
E38: Romosozumab for Osteoporosis
E37: TRACE-RA Atorvastatin for Primary Prevention of CVD in RA
E36: Baricitinib for SLE
E35: Tramadol Associated with All Cause Mortality
E34: Leggo my Eggo! Eggs, Cholesterol, CVD, Mortality
E33: FDG-PET for GCA
E32: TaSER and ARCTIC: U/S to Guide Treatment in Inflammatory Arthritis
E31: SEAM and MIPA Trials: MTX vs. ETN for Psoriatic Arthritis
E30: The Quality of RCTs in the Rheum Literature
E29: CIRT and CANTOS - Immunotherapy for Cardiovascular Disease